Tamoxifen is one of the most widely prescribed drugs used to prevent the recurrence of breast cancer. A non-steroidal antiestrogen, it has been successful in treating postmenopausal women at nearly all stages of breast cancer. Despite its popularity, however, disturbing questions remain about the use of this drug. How effective is tamoxifen in treating patients who have hormone-insensitive breast tumours or who have not yet reached menopause? What are the potential risks in taking tamoxifen, and do they ever outweigh its ...
Read More
Tamoxifen is one of the most widely prescribed drugs used to prevent the recurrence of breast cancer. A non-steroidal antiestrogen, it has been successful in treating postmenopausal women at nearly all stages of breast cancer. Despite its popularity, however, disturbing questions remain about the use of this drug. How effective is tamoxifen in treating patients who have hormone-insensitive breast tumours or who have not yet reached menopause? What are the potential risks in taking tamoxifen, and do they ever outweigh its benefits? Should tamoxifen be administered as a prophylactic drug for healthy premenopausal women who are at high risk of developing breast cancer? In this book, two leading scientific investigators present a balanced and accessible discussion of the diagnosis of breast cancer and the risks, benefits, and limitations of treatment alterntives, particularly tamoxifen. Michael W. DeGregorio and Valerie Wiebe discuss the history and evolution of tamoxifen as a treatment for breast cancer, explaining how it works, what its side effects are, and why tamoxifen treatment is unsuccessful for some women. They present the controversies surrounding the National Cancer Institute's study of tamoxifen as a preventive for breast cancer, describing the hopes of the proponents of the study and the fears of its detractors (potential risks to womcn in the study include thrombosis, uterine cancer, and even breast cancer itself). The book is also an aid to women faced with decisions about treatment or prevention of breast cancer.
Read Less
Add this copy of Tamoxifen and Breast Cancer to cart. $22.99, like new condition, Sold by Robin Books rated 1.0 out of 5 stars, ships from Kingston, ON, CANADA, published 1994 by Yale University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Fine Light shelf wear, otherwise the book is like new, tight with clean unmarked pages Quality Books Because We Care-Shipped from Canada Usually ships within 1-2 business days If you buy this book from us, we will donate a book to a local school We donate 10, 000+ books to local schools every year If there are any problems, pleases ask us to resolve it amicably before leaving any feedback.
Add this copy of Tamoxifen and Breast Cancer (Yale Fastback Series) to cart. $26.24, very good condition, Sold by Midtown Scholar Bookstore rated 5.0 out of 5 stars, ships from Harrisburg, PA, UNITED STATES, published 1994 by Yale University Press.
Add this copy of Tamoxifen & Breast Cancer? What Everyone Should Know to cart. $46.50, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 1994 by Yale University Press.
Add this copy of Tamoxifen and Breast Cancer (Yale Fastback Series) to cart. $195.50, new condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 1994 by Yale University Press.
